Update on COVID-19 vaccination in pediatric solid organ transplant recipients
- PMID: 35060251
- DOI: 10.1111/petr.14235
Update on COVID-19 vaccination in pediatric solid organ transplant recipients
Abstract
Background: COVID-19 vaccination has been successful in decreasing rates of SARS-CoV-2 infection in areas with high vaccine uptake. Cases of breakthrough SARS-CoV-2 infection remain infrequent among immunocompetent vaccine recipients who are protected from severe COVID-19. Robust data demonstrate the safety, immunogenicity, and effectiveness of several COVID-19 vaccine formulations. Importantly, Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine studies have now included children as young as 5 years of age with safety, immunogenicity, and effectiveness data publicly available. In the United States, emergency use authorization by the Federal Drug Administration and approval from the Centers for Disease Control/Advisory Committee on Immunization Practices have been provided for the 5- to 11-year-old age group.
Methods: Members of the International Pediatric Transplant Association (IPTA) provide an updated review of current COVID-19 vaccine data with focus on pediatric solid organ transplant (SOT)-specific issues.
Results: This review provides an overview of current COVID-19 immunogenicity, safety, and efficacy data from key studies, with focus on data of importance to pediatric SOT recipients. Continued paucity of data in the setting of pediatric transplantation remains a challenge.
Conclusions: Further studies of COVID-19 vaccination in pediatric SOT recipients are needed to better understand post-vaccine COVID-19 T-cell and antibody kinetics and determine the optimal vaccine schedule. Increased COVID-19 vaccine acceptability, uptake, and worldwide availability are needed to limit the risk that COVID-19 poses to pediatric solid organ transplant recipients.
Keywords: COVID-19; SARS-CoV-2; children; immunization; solid organ transplantation; vaccination; vaccine.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.Front Immunol. 2022 Feb 23;13:832501. doi: 10.3389/fimmu.2022.832501. eCollection 2022. Front Immunol. 2022. PMID: 35281023 Free PMC article.
-
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.Clin Infect Dis. 2023 May 24;76(10):1761-1767. doi: 10.1093/cid/ciad016. Clin Infect Dis. 2023. PMID: 36636955 Free PMC article.
-
COVID-19 vaccination in pediatric solid organ transplant recipients-Current state and future directions.Pediatr Transplant. 2021 Sep;25(6):e14031. doi: 10.1111/petr.14031. Epub 2021 Jun 2. Pediatr Transplant. 2021. PMID: 34076928 Free PMC article. Review.
-
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):859-868. doi: 10.15585/mmwr.mm7126e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35771731
-
Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.Front Immunol. 2022 Jun 1;13:906225. doi: 10.3389/fimmu.2022.906225. eCollection 2022. Front Immunol. 2022. PMID: 35720376 Free PMC article. Review.
Cited by
-
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children.NPJ Vaccines. 2024 Apr 5;9(1):73. doi: 10.1038/s41541-024-00866-4. NPJ Vaccines. 2024. PMID: 38580714 Free PMC article.
-
Approach to vaccinating the pediatric solid organ transplant candidate and recipient.Front Pediatr. 2023 Nov 8;11:1271065. doi: 10.3389/fped.2023.1271065. eCollection 2023. Front Pediatr. 2023. PMID: 38027303 Free PMC article.
-
A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients.Front Pediatr. 2023 Sep 4;11:1252495. doi: 10.3389/fped.2023.1252495. eCollection 2023. Front Pediatr. 2023. PMID: 37732007 Free PMC article. Review.
-
Survey of pediatric transplant center practices regarding COVID-19 vaccine mandates for transplant candidates and living donors and use of COVID-19-positive deceased organs.Pediatr Transplant. 2023 Sep;27(6):e14513. doi: 10.1111/petr.14513. Epub 2023 Mar 20. Pediatr Transplant. 2023. PMID: 36939212 Free PMC article.
-
The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease.J Bras Nefrol. 2023 Apr-Jun;45(2):244-251. doi: 10.1590/2175-8239-JBN-2022-0081en. J Bras Nefrol. 2023. PMID: 36282106 Free PMC article.
References
REFERENCES
-
- Siegel DA, Reses HE, Cool AJ, et al. Trends in COVID-19 cases, emergency department visits, and hospital admissions among children and adolescents aged 0-17 years - United States, august 2020-august 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1249-1254.
-
- Delahoy MJ, Ujamaa D, Whitaker M, et al. Hospitalizations associated with COVID-19 among children and adolescents - COVID-NET, 14 States, march 1, 2020-august 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1255-1260.
-
- American Academy of Pediatrics (AAP). Children and COVID-19: state-level data report. September 9, 2021. Available at: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/.... Accessed September 18, 2021.
-
- Center for Disease Control and Prevention. National center for health statistics. weekly updates by select demographic and geographic characteristics. Available at: https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm#SexAndAge. Accessed September 18, 2021.
-
- Riffe T, Acosta E. Team TC-D. Data resource profile: COVerAGE-DB: a global demographic database of COVID-19 cases and deaths. Int J Epidemiol. 2021;50(2):390-f.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous